Xiao Juan Li
Director/Board Member presso CHINA NATIONAL MEDICINES CORPORATION LTD.
Profilo
Xiao Juan Li is currently a Director at China National Medicines Co., Ltd.
Prior to this, she worked as a Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and as a Manager-Investment Planning & Audit Division at China National Pharmaceutical Industry Corp.
Ltd.
Posizioni attive di Xiao Juan Li
| Società | Posizione | Inizio |
|---|---|---|
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 07/04/2022 |
Precedenti posizioni note di Xiao Juan Li
| Società | Posizione | Fine |
|---|---|---|
China National Pharmaceutical Industry Corp. Ltd.
 China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Corporate Officer/Principal | - |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
China National Pharmaceutical Industry Corp. Ltd.
China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Xiao Juan Li
